|
|
|
|
| Join Jon O'Connell and experts on this Cell & Gene Live event, exploring whether minimum viability can help gene therapy developers make smarter sourcing decisions — from research-grade production through clinical and commercial phases, where cost and quality can make or break a product. Registration is free with support from Roche CustomBiotech. |
|
|
|
|
As the cell therapy space evolves beyond T cells, allogeneic natural killer (NK) cell therapies are emerging as a scalable and accessible approach in cancer immunotherapy. Experts Raphael Ognar and Tracy Ryan discuss how their teams are advancing the field through distinct yet complementary strategies. The dynamic discussion highlighted the scientific innovation, technological differentiation, and patient-centered vision driving the next generation of allogeneic NK cell therapies. |
|
|
| The Power Of AI To Improve Clinical Trial Monitoring | Article | By Nicola Phillips and Tameka Johnson, inSeption Group | By analyzing patient data sets, AI enhances predictive analytics, supports real-time patient alerts, and strengthens continuous monitoring — improving the effectiveness of clinical trial oversight. |
|
|
|
|
| The Evolving Landscape Of Oncology Drug Development | Article | By Louise Scott, Ph.D., Catalyst Oncology | Oncology drug development is accelerating through precision medicine, biotechnological innovation, and novel modalities like ADCs, immunotherapies, and radiopharmaceuticals, improving outcomes amid cancer incidence. |
|
|
| Data-Driven Physician Engagement For Ultra-Rare Diseases | Case Study | Quest Diagnostics | How can an effective partnership help you leverage advanced data analytics to address the challenges of clinical trials focused on ultra-rare diseases? See how we harness advanced data analytics and expert collaboration. |
|
|
| Why Asia Should Be Your Next Trial Destination | Article | Avance Clinical | Many U.S. oncology sponsors are expanding their late-phase trials into Asia to secure access to rich patient pools, leverage efficient regulatory pathways, and save time and money in the clinic. |
|
|
| A Practical Guide To Patient Recruitment Excellence | Article | OpenClinica | Top-performing clinical trials treat recruitment as a science — thinking like patients, acting fast, and engaging communities with intention, not outdated tactics like bulletin board flyers. |
|
|
| How To Partner With Your CRA For Best Trial Outcomes | Podcast | Novotech | An effective partnership with your CRA hinges on open, early communication, transparency, and collaboration to proactively solve challenges, ensuring patient safety and successful, compliant trial outcomes. |
|
|
| Redefining Accessibility For Pediatric Patients | Case Study | MRN - Medical Research Network | Clinical trials for pediatric patients benefit from flexible delivery at safe locations, reducing participation burdens, enhancing family engagement, and improving retention and outcomes. |
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
|
|
|
|
A conversation with Mark Drinan, Takeda Pharmaceuticals International AG | The ISPE's new guide addresses software for managing digital assets related to qualification, verification, validation, and compliance assurance, establishing robust frameworks. | |
|
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|